Dr Reddys Laboratories (RDY) Dividends Paid - Common (2009)
Dr Reddys Laboratories (RDY) posted quarterly Dividends Paid - Common of -$9.0 million for Q4 2009, down 280.0% quarter-over-quarter from $5.0 million in Q3 2009.
Dr Reddys Laboratories (RDY) Dividends Paid - Common (2009) Analysis & Trends
Dr Reddys Laboratories' Dividends Paid - Common history runs 1 years deep, the most recent figure standing at -$9.0 million for Q4 2009.
- In Q4 2009, Dividends Paid - Common changed N/A year-over-year to -$9.0 million; the TTM figure through Dec 2009 stood at $116.9 million (changed N/A YoY), while the FY2026 annual figure was $71.0 million, down 8.97% from the prior year.
- Dividends Paid - Common for Q4 2009 stood at -$9.0 million, down from $5.0 million in the prior quarter.
- The five-year high for Dividends Paid - Common was $120.0 million in Q2 2009, with the low at -$9.0 million in Q4 2009.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Div. Paid (Common) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 223.00 Mn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | -941.91 Mn |
| 5 | United Therapeutics | 22.19 Bn | 19.53 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.68 Bn | 17.79 Bn | 1.46 Bn | 139.80 Mn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | - |
| 10 | Alkermes | 8.12 Bn | 7.46 Bn | 397.90 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2009 | -9.00 Mn |
| Dec 31, 2009 | -9.00 Mn |
| Sep 30, 2009 | 5.00 Mn |
| Sep 30, 2009 | 5.00 Mn |
| Jun 30, 2009 | 120.00 Mn |
| Jun 30, 2009 | 120.00 Mn |